Ben Franklin Technology Partners of Southeastern Pennsylvania

Avisi Technologies Inc. is focused on developing innovative solutions to combat glaucoma, a leading cause of irreversible blindness. The company has created VisiPlate, a next-generation aqueous shunt designed for mid to late-stage glaucoma treatment. This product is notable for its ultrathin design, being 20 times thinner than a human hair, which facilitates a less invasive insertion procedure that reduces operating time and simplifies follow-up care. VisiPlate is constructed from alumina, a material recognized for its use in hip replacements, thus ensuring biocompatibility. Founded in 2017 and headquartered in Philadelphia, Pennsylvania, Avisi Technologies aims to address the challenges associated with current glaucoma treatments, including patient non-compliance and post-operative complications, ultimately striving to prevent blindness in affected individuals.

Avisi Technologies Inc. is focused on developing innovative solutions to combat glaucoma, a leading cause of irreversible blindness. The company has created VisiPlate, a next-generation aqueous shunt designed for mid to late-stage glaucoma treatment. This product is notable for its ultrathin design, being 20 times thinner than a human hair, which facilitates a less invasive insertion procedure that reduces operating time and simplifies follow-up care. VisiPlate is constructed from alumina, a material recognized for its use in hip replacements, thus ensuring biocompatibility. Founded in 2017 and headquartered in Philadelphia, Pennsylvania, Avisi Technologies aims to address the challenges associated with current glaucoma treatments, including patient non-compliance and post-operative complications, ultimately striving to prevent blindness in affected individuals.

Avisi Technologies Inc. is focused on developing innovative solutions to combat glaucoma, a leading cause of irreversible blindness. The company has created VisiPlate, a next-generation aqueous shunt designed for mid to late-stage glaucoma treatment. This product is notable for its ultrathin design, being 20 times thinner than a human hair, which facilitates a less invasive insertion procedure that reduces operating time and simplifies follow-up care. VisiPlate is constructed from alumina, a material recognized for its use in hip replacements, thus ensuring biocompatibility. Founded in 2017 and headquartered in Philadelphia, Pennsylvania, Avisi Technologies aims to address the challenges associated with current glaucoma treatments, including patient non-compliance and post-operative complications, ultimately striving to prevent blindness in affected individuals.

Animotion is affordable mobile technology for joint care. Our data facilitates more accurate diagnoses, individualized motivation for at-home treatment, and monitored assessment of effectiveness to reduce readmissions and improve quality of care. Animotion links to web and mobile software applications for real-time instant access.

Orange Maker, LLC is a 3D printing technology company based in Thousand Oaks, California, that specializes in developing advanced 3D printing systems and user-friendly software. Founded in 2014 by Doug Farber and Kurtis Dudley, the company has created the Helios One, a high-resolution 3D printing system utilizing heliolithography technology. Orange Maker focuses on enabling professional designers and engineers to realize their visions by providing innovative solutions that support various applications, including aerospace, architecture, automotive, biotech, and medical industries. The company’s advanced technology allows for flexible manufacturing with a range of compatible materials and smooth surface finishes, facilitating seamless integration between digital designs and physical products. Orange Maker is committed to fostering a collaborative culture within the 3D printing community, empowering users to imagine and create without limitations.

Allevi develops tools for designing and engineering 3D tissues, specializing in desktop 3D bioprinters that create functional living tissues. The company's offerings include bioinks composed of collagen and hyaluronic acid, alongside a cloud-based platform called Bioprint Online, which allows users to design structures, define materials, and monitor the printing process. Allevi's products are utilized by researchers in tissue engineering, regenerative medicine, material science, and cell biology, as well as by industrial and pharmaceutical companies for drug testing and development. The company's bioinks are available for purchase online. Founded in 2014 and based in Philadelphia, Pennsylvania, Allevi was previously known as BioBots, Inc.

Allevi develops tools for designing and engineering 3D tissues, specializing in desktop 3D bioprinters that create functional living tissues. The company's offerings include bioinks composed of collagen and hyaluronic acid, alongside a cloud-based platform called Bioprint Online, which allows users to design structures, define materials, and monitor the printing process. Allevi's products are utilized by researchers in tissue engineering, regenerative medicine, material science, and cell biology, as well as by industrial and pharmaceutical companies for drug testing and development. The company's bioinks are available for purchase online. Founded in 2014 and based in Philadelphia, Pennsylvania, Allevi was previously known as BioBots, Inc.

EyeIC, Inc. develops and commercializes imaging technologies for medical applications. The company serves eye care professionals and eye clinics. It offers MatchedFlicker, a device for monitoring the advent and progression of glaucoma through change detection in time series retinal photographs. The company's software works by aligning and registering two images of the same object taken at different points in time, and then generating a superimposed view that is alternated back and forth. The company was founded in 2004 and is based in Wayne, Pennsylvania.

OneTwoSee is a Philadelphia-based company specializing in the development of sports game-centers that enhance fan engagement through real-time statistics, game data, advanced analytics, and social media integration. It offers licensed, white-labeled products that can be seamlessly incorporated into customers' branded websites and platforms, accessible across various devices such as PCs, tablets, smartphones, smart TVs, and in-arena displays. The company serves a diverse clientele, including regional and national sports networks, newspaper publishers, and consumer electronics firms, allowing them to effectively engage and monetize their audiences with high-value advertising and sponsorship opportunities. OneTwoSee's scalable technology platform enables partners to realize immediate returns on investment while delivering a rich, interactive experience for sports fans.

Real Time Tomography, LLC develops imaging software solutions for medical imaging systems. The company offers Adara, an image processing and enhancement software for digital mammography that provides optimal tissue contrast and lesion conspicuity; and Briona, a 3D image reconstruction software for digital breast tomosynthesis that reconstructs 3D tomographic images from 2D projection images. It also provides technical support and consultation on detector and system design for optimal image quality and processing speed. The company provides its products to the manufacturers of mammography and PACS workstations. Real Time Tomography, LLC was founded in 2006 and is based in Villanova, Pennsylvania.

GTronix applies proprietary programmable analog technology and novel design techniques to realize sophisticated DSP algorithms in analog integrated circuits yielding smaller, lower-power solutions than traditional DSP implementations. The company’s initial product line breaks new ground in analog performance and programmability with the lowest power beamsteering solution on the market.